Proficio Capital Partners LLC Biomarin Pharmaceutical Inc Transaction History

Proficio Capital Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$87.74 - $117.27 $2.47 Million - $3.31 Million	28,200 New	28,200 $2.74 Million
Q3 2019 Nov 13, 2019	SELL	$67.4 - $85.11 $16,041 - $20,256	-238 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$80.35 - $93.9 $18,319 - $21,409	-228 Reduced 48.93%	238 $20,000
Q1 2019 May 13, 2019	BUY	$84.2 - $98.62 $505 - $591	6 Added 1.3%	466 $41,000
Q4 2018 Feb 08, 2019	SELL	$80.14 - $106.07 $2,484 - $3,288	-31 Reduced 6.31%	460 $39,000
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $563 - $634	6 Added 1.24%	491 $48,000
Q2 2018 Aug 10, 2018	BUY	$76.01 - $99.03 $23,335 - $30,402	307 Added 172.47%	485 $46,000
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $2,951 - $3,519	-38 Reduced 17.59%	178 $14,000
Q4 2017 Feb 09, 2018	SELL	$80.76 - $95.13 $242 - $285	-3 Reduced 1.37%	216 $19,000
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $17,651 - $20,794	219	219 $20,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.